Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
2(66.7%)
Phase 1
1(33.3%)
3Total
Phase 3(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03152747Completed

Influence of Posterior Vitreous Detachment on Retinal Detachment After Lens Surgery in Myopic Eyes

Role: collaborator

NCT05158699Phase 3Terminated

Effectiveness of Periocular Drug Injection in CATaract Surgery

Role: collaborator

NCT04011696Completed

Monofocal Extended Range of Vision (MERoV) Study

Role: collaborator

NCT01774474Phase 3Completed

PRevention of Macular EDema After Cataract Surgery

Role: collaborator

NCT00845117Phase 1Unknown

Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell Deficiency

Role: collaborator

All 5 trials loaded